ERAS Logo

Erasca, Inc. (ERAS) 

NASDAQ
Market Cap
$571.66M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
75 of 809
Rank in Industry
60 of 445

Largest Insider Buys in Sector

ERAS Stock Price History Chart

ERAS Stock Performance

About Erasca, Inc.

Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. It is also developing ERAS-801, a central nervous system-penetrant EGFR inhibitor for the treatment of patients with recurrent glioblastoma multiforme. The company was incorporated in 2018 and is headquartered in San Diego, California.

Insider Activity of Erasca, Inc.

Over the last 12 months, insiders at Erasca, Inc. have bought $3.97M and sold $0 worth of Erasca, Inc. stock.

On average, over the past 5 years, insiders at Erasca, Inc. have bought $9.04M and sold $3.75M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Lim Jonathan E (Chairman & CEO) — $7.44M. Casdin Alexander W. (director) — $231,705. Start Valerie Denise Harding (director) — $18,480.

The last purchase of 80,000 shares for transaction amount of $181,920 was made by Casdin Alexander W. (director) on 2024‑05‑21.

List of Insider Buy and Sell Transactions, Erasca, Inc.

2024-05-21PurchaseCasdin Alexander W.director
80,000
0.0447%
$2.27$181,920+0.43%
2023-12-06PurchaseLim Jonathan EChairman & CEO
278,150
0.1825%
$1.72$478,418+17.61%
2023-12-06PurchaseStart Valerie Denise Hardingdirector
10,000
0.007%
$1.85$18,480+17.61%
2023-12-05PurchaseLim Jonathan EChairman & CEO
721,850
0.4606%
$1.69$1.22M+18.34%
2023-12-04PurchaseCasdin Alexander W.director
30,000
0.0197%
$1.66$49,785+22.26%
2023-10-05PurchaseLim Jonathan EChairman & CEO
1M
0.695%
$2.03$2.03M-0.47%
2023-06-08PurchaseLim Jonathan EChairman & CEO
100,000
0.0676%
$2.75$275,000-18.38%
2023-04-10PurchaseCasdin Alexander W.director
20,000
0.0135%
$2.76$55,230-14.44%
2023-03-28PurchaseLim Jonathan EChairman & CEO
100,000
0.0693%
$2.84$284,000-12.41%
2023-01-10PurchaseLim Jonathan EChairman & CEO
60,000
0.0413%
$3.86$231,420-29.33%
2022-12-21PurchaseBristol James Arthurdirector
20,000
0.0162%
$4.14$82,800-35.48%
2022-12-21PurchaseStart Valerie Denise Hardingdirector
10,000
0.0091%
$4.64$46,400-35.48%
2022-12-15PurchaseCasdin Alexander W.director
20,000
0.0167%
$4.87$97,490-42.71%
2022-12-14PurchaseLim Jonathan EChairman & CEO
40,000
0.0338%
$4.99$199,600-43.44%
2022-12-13PurchaseChen Bihuadirector
307,692
0.3325%
$6.50$2M-44.42%
2021-08-10PurchaseChen Bihuadirector
200,000
0.2202%
$22.10$4.42M-41.38%
2021-07-26SaleChen Bihuadirector
200,000
0.2009%
$18.77$3.75M-35.23%
2021-07-20PurchaseChen Bihuadirector
950,000
0.7974%
$16.00$15.2M-35.39%
2021-07-20PurchaseMultani Pratik Sdirector
6,200
0.0052%
$16.00$99,200-35.39%
2021-07-20PurchaseHambleton Juliedirector
6,000
0.005%
$16.00$96,000-35.39%

Insider Historical Profitability

<0.0001%
Lim Jonathan EChairman & CEO
12899360
8.5377%
$2.2070<0.0001%
Casdin Alexander W.director
573974
0.3269%
$2.2040<0.0001%
Start Valerie Denise Hardingdirector
20000
0.0132%
$2.2030<0.0001%
Chen Bihuadirector
10813246
7.157%
$2.2031<0.0001%
Multani Pratik Sdirector
172866
0.1144%
$2.2010<0.0001%
Bristol James Arthurdirector
20000
0.0132%
$2.2010<0.0001%
Hambleton Juliedirector
6000
0.004%
$2.2010<0.0001%
Garner EbunGeneral Counsel
900
0.0006%
$2.2010<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Arch Venture Management Llc$22.77M4.6511.06M0%+$032.36
BlackRock$14.38M2.936.98M-4.5%-$678,051.10<0.0001
Armistice Capital Llc$12.71M2.596.17M-23.77%-$3.96M0.15
Artal Group S A$9.73M1.984.72M0%+$00.05
The Vanguard Group$8.94M1.824.34M+14.39%+$1.12M<0.0001
Prosight Management Lp$7.54M1.543.66M+510.51%+$6.3M2.1
PFM Health Sciences$5.22M1.072.54M-1.57%-$83,242.540.14
Sio Capital Management LLC$5M1.022.43MNew+$5M1.77
Bank of America$4.53M0.922.2M+202.66%+$3.03M<0.0001
Schroder Investment Management Group$3.97M0.811.93M0%+$00.01
Geode Capital Management$3.9M0.81.89M+4.39%+$164,060.84<0.0001
State Street$3.44M0.71.67M+0.32%+$11,084.86<0.0001
Renaissance Technologies$3.36M0.691.63M-18.77%-$776,391.820.01
Goldman Sachs$3.26M0.671.58M+21.97%+$587,046.45<0.01
Cvi Holdings Llc$3M0.611.46MNew+$3M3.1
Millennium Management LLC$2.38M0.491.15M-22.26%-$680,784.74<0.01
Point72 Asset Management$2.26M0.461.1MNew+$2.26M<0.01
Two Sigma$2.21M0.451.07M+7.43%+$152,722.20<0.01
Two Sigma Advisers LP$2.13M0.441.04M+65.35%+$843,364.00<0.01
EDBI Pte Ltd$1.83M0.37888,8880%+$02.08
Woodline Partners LP$1.84M0.37890,793-3.08%-$58,351.570.02
Citadel Advisors LLC$1.72M0.35837,314-61.01%-$2.7M<0.01
Nuveen$1.42M0.29690,201-42.48%-$1.05M<0.0001
Charles Schwab$1.37M0.28663,870+2.11%+$28,294.10<0.0001
Northern Trust$1.36M0.28662,486-5.48%-$79,167.85<0.0001
Morgan Stanley$1.36M0.28658,225-4.86%-$69,193.37<0.0001
Gsa Capital Partners Llp$1.17M0.24569,039-14.79%-$203,510.340.09
Acadian Asset Management$713,000.000.15346,953+286.45%+$528,501.16<0.01
D. E. Shaw & Co.$660,691.000.14320,724+213.69%+$450,070.56<0.01
Dimensional Fund Advisors$659,737.000.14320,261-14.87%-$115,209.51<0.0001
BNY Mellon$536,962.000.11260,661-7.92%-$46,183.17<0.0001
ExodusPoint Capital Management, LP$514,000.000.11249,518New+$514,000.000.01
Regents Of The University Of California$486,646.000.1236,2360%+$00.14
Xtx Topco Ltd$470,354.000.1228,327-2.69%-$13,015.090.03
Silverarc Capital Management Llc$461,121.000.09223,845New+$461,121.000.14
IPG INVESTMENT ADVISORS, LLC$427,388.000.09207,470New+$427,388.000.09
Pennant Capital Management Llc$342,372.000.07166,2000%+$00.05
Connor Clark & Lunn Investment Management Ltd$305,051.000.06148,083+1.44%+$4,319.82<0.01
Fidelity Investments$285,621.000.06138,651+139.33%+$166,281.11<0.0001
Exchange Traded Concepts, LLC$282,195.000.06136,988+152.1%+$170,256.770.01
AQR Capital$251,654.000.05122,162New+$251,654.00<0.0001
RhumbLine Advisers$250,302.000.05121,509+3.32%+$8,039.97<0.0001
AllianceBernstein$243,719.000.05118,3100%+$0<0.0001
Jane Street Capital$237,399.000.05115,242-56.75%-$311,497.35<0.0001
Pale Fire Capital Se$230,526.000.05111,906-39.87%-$152,841.46<0.01
Susquehanna Fundamental Investments Llc$215,663.000.04104,691New+$215,663.000.01
Tang Capital Management, LLC$206,000.000.04100,000-33.33%-$103,000.00<0.01
Walleye Capital$195,861.000.0495,078-31.79%-$91,260.21<0.01
Denali Advisors$187,872.000.0491,2000%+$00.06
American Century Investments$169,929.000.0482,490+36.72%+$45,641.25<0.0001